Daniel Emersleben - Profile and Investment Details

Investor Profile

Daniel Emersleben is a Investment Bank, Private Equity Firm based in United Kingdom with a diverse investment portfolio that includes companies such as AM Pharma, FeetMe, LumApps, Ambler, Livestorm, Banook, Onoff, CapCar, JobTeaser, Glovo, ACINQ, Swile, IO Biotech, Kactus, Kaia Health, Mediliant, wefox, Vico Therapeutics, WeRide.ai, DNA Script, Alma, BreezoMeter, Laboratories JUVISE Pharmaceuticals, Colonies, THIS, RIVE Private Investment, Silvr, Tacalyx, Ornikar, TeleClinic, Immotor, Onfido, Music World Media, Sensome, Circ, Heetch, Troops, Ynsect, TrustInSoft, Jenji, Corlieve Therapeutics, Minoryx Therapeutics, Yubo, Bird, Ceva Santé Animale, Frulact, Nosto, Eurazeo, Colisée, Malt, Botify, Homa Games, CetteFamille, Comet Meetings, Majelan, +Simple.frCardiologs, Andjaro, Withings, Dishangtie, Iroko, Asarina Pharma, Vestiaire Collective, PathoQuest, Ogury, Lifen, inmemori, Shipfix, Cove, Stockly, Peakon, BioSerenity, Transcend Software, SOPHiA GENETICS, Ermium Therapeutics, WeMaintain, Pharvaris, Foliateam, Sunfire, Cooptalis, Alsid, Meero, Jabmo, Stilla Technologies, Lifebit, OnTruck, . Over time, Daniel Emersleben has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Daniel Emersleben is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, E-commerce, Customer Service, Payments, Equities Trading, Wellness, Fundraising, Equities, Investment Management, Customer Engagement, Strategic Partnerships, Banking, Education, Retail, Finance, Biotechnology, Fashion, Cosmetics, Market Research, Content, FinTech, Consumer Internet, Consulting, B2C, Financial Risk Management, Lending, Cross-Border Payments, Medical, Information Technology, B2B, Real Estate, Therapeutics, Financial Advisory, Machine Learning, Personal Health, Risk Management, Trading, Sponsorship may find it worthwhile to explore potential connections with Daniel Emersleben, as their portfolio suggests a familiarity and interest in this area.

Understanding Daniel Emersleben’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.